CYTOPLAST GBR
Device Facts
| Record ID | K964342 |
|---|---|
| Device Name | CYTOPLAST GBR |
| Applicant | Osteogenics Co. |
| Product Code | LYC · Dental |
| Decision Date | Mar 11, 1997 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3930 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
A temporarily implantable material (non-resorbable) for use as a space-making barrier in the treatment of periodontal defects.
Device Story
Cytoplast™ GBR is a non-absorbable barrier membrane; composed of nanoporous high-density polytetrafluoroethylene (n-PTFE) film; 250-micron nominal thickness. Used in dental surgery to facilitate bone regeneration by acting as a space-making barrier over periodontal defects. Supplied sterile in various shapes/sizes. Implanted by clinicians; provides physical barrier to prevent soft tissue ingrowth into bone defect sites; promotes bone healing. Biocompatibility established via history of PTFE use in vascular/cardiovascular implants.
Clinical Evidence
No clinical data provided; substantial equivalence based on identical composition and function to predicate devices and established biocompatibility of PTFE material.
Technological Characteristics
Material: Nanoporous high-density polytetrafluoroethylene (n-PTFE) film. Dimensions: 250-micron nominal thickness. Form factor: Various shapes/sizes. Sterilization: Sterile. Energy source: None (passive implant).
Indications for Use
Indicated for patients requiring space-making barriers for the treatment of periodontal defects.
Regulatory Classification
Identification
Bone grafting material is a material such as hydroxyapatite, tricalcium phosphate, polylactic and polyglycolic acids, or collagen, that is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.
Special Controls
*Classification.* (1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval. (c) *Date premarket approval application (PMA) or notice of product development protocol (PDP) is required.* Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
Predicate Devices
- Gore-Tex™ Regenerative Material (K922627)
- TefGen-FD (K935137)
- Imtec Biobarrier Membrane (K950306)
Related Devices
- K972278 — CYTOPLAST REGENTEX TITANIUM 250 · Osteogenics Co. · Aug 6, 1997
- K012144 — CYTOFLEX · Unicare Biomedical, Inc. · Oct 1, 2001
- K160493 — Cytosurg non-resorbable PTFE Membrane, 25mm x 30mm, Cytosurg non-resorbable PTFE Membrane, 12mm x 24mm · Salvin Dental Specialties · Sep 8, 2016
- K974752 — IMTEC/BIOBARRIER MEMBRANE · Imtec Corp. · Mar 3, 1998
- K201187 — Cytoplast Titanium-Reinforced PTFE Membranes · Osteogenics Biomedical, Inc. · Jan 23, 2021